MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
ODI (Oswestry Disability Index) PDF Print E-mail

Developed by:
Fairbank JCT, Couper J, Davies JB, O’Brien JP (UK)

Objective:
To indicate the extent to which a person’s functional level is restricted by disability

Copyright:
ODI © Jeremy Fairbank, 1980. All Rights Reserved.

Reference publications:
Fairbank J, Pynsent PB. The Oswestry Disability Index. Spine 2000; 25(22):2940-2953

Fairbank JCT, Couper J, Davies JB, O’Brien JP. The Oswestry Low Back Pain Disability Questionnaire. Physiotherapy. 1980;66:271-273



Conditions of use:


1. User-Agreement

User is required to complete and sign a User Agreement in which specific conditions requested by the Authors are detailed.


2. Access fees

carre6 Authors' royalty fees

Authors' royalty fees are requested according to the study design and context of use of the questionnaire:

- In academic research and individual clinical practice: free of charge

- In commercial studies (1) involving "for-profit" organizations and academic studies funded by commercial companies: 500 Euros per protocol/application plus an additional 500 Euros per available language version (original version and translated versions)

Other specific conditions requested by the Authors are detailed in the User Agreement.


carre6 Distribution fees

Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge

- In funded academic research (2): 300 €* per study + 50 € per language version 

- In commercial studies (1) involving "for-profit" organizations and academic studies funded by commercial companies: 500 €* per study + 150 € per language version. 


* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies)


Use Requirements:

For all new studies, version 2.1a of the ODI must be used.


Review Copy:


English version available for review purpose only. Please click here to access


New Translations:

For the production of new translations to be used in commercial studies, each translation shall be coordinated by Mapi Institute.


Contact information:

MAPI Research Trust
Christelle Berne

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


More information on the ODI on PROQOLID


[ BACK ]

 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)  
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)  

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France) 

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PHQ (Patient Health Questionnaire Screeners
Pfizer Inc. (USA)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA) 


To access our catalog, please click here.



Coming soon!

Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)


For any information, please contact:
contact@mapi-trust.org